Supporting the immune system in the fight against lung cancer cells

03/26: New CD Laboratory at the Medical University of Graz

Lung cancer remains the world’s leading cause of cancer-related deaths: that is why Heads of Laboratory Philipp Jost and Michael Dengler and their team at the CD Laboratory for Activation of Immunogenic Cell Death in Lung Cancer at the Med Uni Graz, supported by commercial partner Boehringer Ingelheim RCV GmbH & Co KG, are researching ways to help patients’ immune systems to recognise and specifically target tumour cells, thereby improving survival rates and quality of life for those affected!

CD Laboratory for Activation of Immunogenic Cell Death in Lung Cancer

Head of research unit

Ass.Prof. Dr. Michael Dengler

Medizinische Universität Graz

Duration

01.01.2026 - 31.12.2032

Commercial Partner

Boehringer Ingelheim RCV GmbH & Co KG

Christian Doppler Forschungsgesellschaft

Boltzmanngasse 20/1/3 | 1090 Wien | Tel: +43 1 5042205 | Fax: +43 1 5042205-20 | office@cdg.ac.at

© 2020 Christian Doppler Forschungsgesellschaft